Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis

Syn, Wing-Kin, Choi, Steve S., Liaskou, Evaggelia, Karaca, Gamze F., Agboola, Kolade M., Oo, Ye Htun, Mi, Zhiyong, Pereira, Thiago A. +15 more·2011·Hepatology
DOI 10.1002/hep.23998

Cited by (276)

Items 101–200 of 276

  1. Liver fibrogenesis and metabolic factors
    Rodolphe Anty, Maud Lemoine · 2011 · Clinics and Research in Hepatology and Gastroenterology
  2. Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
    Sana Raza, Sangam Rajak, Baby Anjum, Rohit A. Sinha · 2019 · Hepatoma Research
  3. Liver macrophages revisited: The expanding universe of versatile responses in a spatiotemporal context
    Guillot, Adrien, Tacke, Frank · 2024 · Hepatology Communications
  4. MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types
    Xiaolin Wang, Wonhyo Seo, Seol Hee Park, Yaojie Fu, Seonghwan Hwang, Robim Marcelino Rodrigues, Dechun Feng, Bin Gao, Yong He · 2021 · International Journal of Biological Sciences
  5. Principles of Liver Regeneration and Growth Homeostasis
    George K. Michalopoulos · 2013 · Comprehensive physiology
  6. CCR2 and CD44 Promote Inflammatory Cell Recruitment during Fatty Liver Formation in a Lithogenic Diet Fed Mouse Model
    Charlotte E. Egan, Erin K. Daugherity, Arlin B. Rogers, Delbert S. Abi Abdallah, Eric Denkers, Kirk J. Maurer · 2013 · PLoS ONE
  7. Increased risk of osteoporosis in patients with nonalcoholic fatty liver disease
    Hon-Jhe Chen, Hao-yu YANG, Kuang-Chieh Hsueh, Cheng‐Che Shen, Ru-Yi Chen, Hsien‐Chung Yu, Tzu-Lin Wang · 2018 · Medicine
  8. Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease
    A. M. Carranza-Trejo, V. Vetvicka, L. Vištejnová, M. Králíčková, E. Montufar · 2021 · Expert Review of Gastroenterology & Hepatology
  9. Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model
    Johannes Haybaeck, Cornelia Stumptner, Andrea Thueringer, Thomas Kolbe, Thomas Michael Magin, Michael Hesse, Peter Fickert, Oleksiy Tsybrovskyy, Heimo Müller, Michael A Trauner et al. · 2012 · Laboratory Investigation
  10. Role of Hedgehog Signaling Pathway in NASH
    Mariana Verdelho Machado, Anna Mae Diehl · 2016 · International Journal of Molecular Sciences
  11. Enhanced Steatosis and Fibrosis in Liver of Adult Offspring Exposed to Maternal High-Fat Diet
    M. D. Thompson, M. Cismowski, A. Trask, Scott W. Lallier, Amanda E. Graf, L. Rogers, P. Lucchesi, D. Brigstock · 2016 · Gene Expression
  12. Hedgehog signaling pathway regulates hexavalent chromium-induced liver fibrosis by activation of hepatic stellate cells
    Junyan Yan, Huarong Huang, Zuping Liu, Jiayuan Shen, Jian Ni, Jiwei Han, Renjun Wang, De-Rong Lin, Baowei Hu, Lifang Jin · 2019 · Toxicology Letters
  13. Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats
    Ying‐Ying Yang, Tung‐Hu Tsai, Yi‐Tsau Huang, Tzung-Yan Lee, Che‐Chang Chan, Kuei‐Chuan Lee, Han‐Chieh Lin · 2011 · Hepatology
  14. Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications
    Ilias D. Vachliotis, Athanasios D. Anastasilakis, Antonis Goulas, Dimitrios G. Goulis, Stergios A. Pοlyzos · 2022 · Diabetes Obesity and Metabolism
  15. Fibrogenesis in alcoholic liver disease
    Hideki Fujii · 2014 · World Journal of Gastroenterology
  16. Non-alcoholic steatohepatitis in morbidly obese patients
    Albert Tran, Philippe Gual · 2013 · Clinics and Research in Hepatology and Gastroenterology
  17. Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: Insight on hedgehog/Gli and Wnt/β-catenin signaling crosstalk
    Marwa O. El-Derany, Ebtehal El‐Demerdash · 2020 · Biochemical Pharmacology
  18. Therapeutic implications of sonic hedgehog pathway in metabolic disorders: Novel target for effective treatment
    Chahat Garg, Heena Khan, Amarjot Kaur, Thakur Gurjeet Singh, Vivek Sharma, Sachin Kumar Singh · 2022 · Pharmacological Research
  19. Tumor necrosis factor-inducible gene 6 reprograms hepatic stellate cells into stem-like cells, which ameliorates liver damage in mouse
    Sihyung Wang, Jieun Kim, Chanbin Lee, Dayoung Oh, Jinsol Han, Tae‐Jin Kim, Sang Woo Kim, Young‐Su Seo, Seh‐Hoon Oh, Youngmi Jung · 2019 · Biomaterials
  20. Immunoregulatory Roles of Osteopontin in Diseases
    L F Wang, Xiaoyin Niu · 2024 · Nutrients
  21. Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma
    Shawky Abdelhamid Fouad, Nagwa Mohamed, Mary Wadie, Doaa Ali Moustafa · 2015 · Hepatitis Monthly
  22. Osteopontin regulates the cross-talk between phosphatidylcholine and cholesterol metabolism in mouse liver
    Maitane Núñez-García, Beatriz Gómez‐Santos, Xabier Buqué, Juan L. García‐Rodríguez, Marta R. Romero, José J.G. Marı́n, Beatriz Arteta, Carmelo García‐Monzón, Luis Antonio Castaño, Wing‐Kin Syn et al. · 2017 · Journal of Lipid Research
  23. Osteopontin Contributes to TGF-β1 Mediated Hepatic Stellate Cell Activation
    Xiao Xiao, Gang Yi, Yong Gu, Lina Zhao, Jindong Chu, Jinfeng Zhou, Xiqiang Cai, Hui Zhang, Li Xu, Yongzhan Nie et al. · 2012 · Digestive Diseases and Sciences
  24. When GLP-1 hits the liver: a novel approach for insulin resistance and NASH
    Yong Ook Kim, Detlef Schuppan · 2012 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  25. Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines
    Fatima A. Rangwala, Kevin P. Williams, Ginger R. Smith, Zainab Thomas, Jennifer L. Allensworth, Herbert Kim Lyerly, Anna Mae Diehl, Michael Andrew Morse, Gayathri R. Devi · 2012 · BMC Cancer
  26. Neutralizing antibody against osteopontin attenuates non-alcoholic steatohepatitis in mice
    Machiko Honda, Chiemi Kimura, Toshimitsu Uede, Shigeyuki Kon · 2020 · Journal of Cell Communication and Signaling
  27. Schistosome-induced cholangiocyte proliferation and osteopontin secretion correlate with fibrosis and portal hypertension in human and murine schistosomiasis mansoni
    Thiago Almeida Pereira, Wing‐Kin Syn, Mariana Verdelho Machado, Paula Vieira Teixeira Vidigal, Vívian Resende, Izabela Voieta, Guanhua Xie, Alba Otoni, Márcia María de Souza, Elisângela Trindade Santos et al. · 2015 · Clinical Science
  28. Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis
    Guang-Ying Cui, Jia-Ning Chen, Zhongwen Wu, Hai-Jun Huang, Lin Wang, Yan Liang, P. Zeng, Jie-Zuan Yang, T. Uede, Hong-Yan Diao · 2018 · Journal of Cellular Physiology
  29. The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression
    Guangyan Wang, Jinjie Duan, Guangyin Pu, Chenji Ye, Yue Li, Wenjing Xiu, Jingwen Xu, Ben Liu, Yi Zhu, Chunjiong Wang · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  30. Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies
    Maria V. Bourganou, Maria Eleni Chondrogianni, Ioannis Kyrou, Christina‐Maria Flessa, Antonios Chatzigeorgiou, Evangelos K. Oikonomou, Vaia Lambadiari, Harpal Singh Randeva, Eva N. Kassi · 2025 · International Journal of Molecular Sciences
  31. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening
    Adélia Simão, João Madaleno, Nuno Silva, Fernando Rodrigues, Paula Caseiro, Nascimento Costa, Armando de Mattos Carvalho · 2015 · BMC Gastroenterology
  32. Hepatocyte programmed cell death: the trigger for inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis
    Zilu Cheng, Huikuan Chu, Ekihiro Seki, Rong Lin, Ling Yang · 2024 · Frontiers in Cell and Developmental Biology
  33. Single-cell transcriptome analysis reveals liver injury induced by glyphosate in mice
    Jiangpeng Wu, Xiuping Sun, Chunyi Wu, Xiaoping Hong, Lulin Xie, Zixu Shi, Liang Zhao, Qingfeng Du, Wei Lie Xiao, Jichao Sun et al. · 2023 · Cellular & Molecular Biology Letters
  34. Anatomy, pathophysiology and basic mechanisms of disease
    James M. Crawford, Alastair D. Burt · 2011 · Elsevier eBooks
  35. Mechanisms of liver fibrosis in metabolic syndrome
    Mehal, Wajahat · 2023 · eGastroenterology
  36. Role of Hepatitis C Virus Induced Osteopontin in Epithelial to Mesenchymal Transition, Migration and Invasion of Hepatocytes
    Jawed Iqbal, Steven McRae, Thi Mai, Krishna K. Banaudha, Mehuli Sarkar-Dutta, Gulam Waris · 2014 · PLoS ONE · Retracted
  37. Hepatic Stellate Cells Express Thymosin Beta 4 in Chronically Damaged Liver
    Jieun Kim, Sihyung Wang, Jeongeun Hyun, Steve S. Choi, Hee‐Jae Cha, Meesun Ock, Youngmi Jung · 2015 · PLoS ONE
  38. Prevalence and Trends in Low Bone Density, Osteopenia and Osteoporosis in U.S. Adults With Non-Alcoholic Fatty Liver Disease, 2005–2014
    Tianyu Zhai, Qi Chen, Jing Xu, Xi Jia, Pu Xia · 2022 · Frontiers in Endocrinology
  39. Biliary fibrosis drives liver repopulation and phenotype transition of transplanted hepatocytes
    Mladen I. Yovchev, Joseph D. Locker, Michael Oertel · 2016 · Journal of Hepatology
  40. Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)
    Pallavi Subramanian, Jochen Hampe, Frank Tacke, Triantafyllos Chavakis · 2022 · International Journal of Molecular Sciences
  41. Structure, Function, and Responses to Injury
    James M. Crawford, Paulette Bioulac‐Sage, Prodromos Hytiroglou · 2017 · Elsevier eBooks
  42. Overexpressed miR‐196a accelerates osteogenic differentiation in osteoporotic mice via GNAS‐dependent Hedgehog signaling pathway
    Li‐Na Zhong, Yu‐Zhu Zhang, Hong Li, Hui‐Ling Fu, Cheng‐Xiu Lv, Xiujuan Jia · 2019 · Journal of Cellular Biochemistry
  43. Osteopontin Promotes Hepatic Progenitor Cell Expansion and Tumorigenicity via Activation of β-Catenin in Mice
    Yingying Liu, Lei Cao, Rui Chen, Xuyu Zhou, Xiaoyu Fan, Yingchao Liang, Rongjie Jia, Hao Wang, Guoke Liu, Yajun Guo et al. · 2015 · Stem Cells
  44. Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease
    Yusuf Nadir Yilmaz, Oğuzhan Öztürk, Yeşim Özen Alahdab, Ebubekir Şenateş, Yaşar Çolak, Hamdi Levent Doğanay, Ender Mehmet Coşkunpınar, Yasemin Musteri Oltulu, Fatih Eren, Özlen Atuğ et al. · 2012 · Digestive and Liver Disease
  45. Significance of MR/OPN/HMGB1 axis in NAFLD-associated hepatic fibrogenesis
    Min Tang, Haoyu Jia, Shuai Chen, Bo Yang, Bhuvanesh Kinish Patpur, Weiping Song, Yizhong Chang, Jing Li, Changqing Yang · 2020 · Life Sciences
  46. Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease
    Tianhao Zhou, Debjyoti Kundu, Jonathan Robles-Linares, Vik Meadows, Keisaku Sato, Leonardo Baiocchi, Burcin Ekser, Shannon S. Glaser, Gianfranco D. Alpini, Heather Francis et al. · 2021 · Cells
  47. Effective delivery of osteopontin small interference RNA using exosomes suppresses liver fibrosis via TGF-β1 signaling
    Min Tang, Cheng Guo, Mengxue Sun, Hao Zhou, Xin Peng, Jianli Dai, Qin Ding, Ying Wang, Changqing Yang · 2022 · Frontiers in Pharmacology
  48. Protein and mRNA expression of Shh, Smo and Gli1 and inhibition by cyclopamine in hepatocytes of rats with chronic fluorosis
    Lina Zhao, Yanni Yu, Chaonan Deng · 2014 · Toxicology Letters
  49. Hedgehog Signaling: Linking Embryonic Lung Development and Asthmatic Airway Remodeling
    Linghui Zeng, Muhammad Qasim Barkat, Shahzada Khurram Syed, Shahid Shah, Ghulam Abbas, Chengyun Xu, Amina Mahdy, Nadia Hussain, Liaqat Hussain, Abdul Majeed et al. · 2022 · Cells
  50. Causal association of NAFLD with osteoporosis, fracture and falling risk: a bidirectional Mendelian randomization study
    Aiyong Cui, Peilun Xiao, Zhiqiang Fan, Jinlai Lei, Shuang Han, Dan-Long Zhang, Xing Chang Wei, Pengfei Wang, Yan Zhuang · 2023 · Frontiers in Endocrinology
  51. The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis
    Virender Kumar, Yuxiang Dong, Vinod Kumar, Saud Almawash, Ram I. Mahato · 2019 · Theranostics
  52. Liver Renewal: Detecting Misrepair and Optimizing Regeneration
    Mariana Verdelho Machado, Anna Mae Diehl · 2014 · Mayo Clinic Proceedings
  53. Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis
    Laila Lavanya Gadipudi, Naresh Naik Ramavath, Alessia Provera, Chris P.M. Reutelingsperger, Emanuele Albano, Mauro Perretti, Salvatore Sutti · 2022 · Clinical Science
  54. Microenvironmental control of the ductular reaction: balancing repair and disease progression
    Giovanni Sorrentino · 2025 · Cell Death and Disease
  55. Liver epithelial focal adhesion kinase modulates fibrogenesis and hedgehog signaling
    Yun Weng, Tyler Jacob Lieberthal, Vivian X. Zhou, Maya A. Lopez-Ichikawa, Manuel Armas‐Phan, Tristan K. Bond, Miya Yoshida, Won‐Tak Choi, Tammy T. Chang · 2020 · JCI Insight
  56. Effect of metformin treatment on circulating osteoprotegerin in patients with nonalcoholic fatty liver disease
    Elena Sofer, Marina Shargorodsky · 2015 · Hepatology International
  57. Epimorphin Alters the Inhibitory Effects of SOX9 on Mmp13 in Activated Hepatic Stellate Cells
    J.P. Pritchett, Varinder Singh Athwal, Emma Harvey, Katherine Martin, Jessica Llewellyn, Philip Ireland, Alexander Nicolaides, Martin James Humphries, Nicoletta Bobola, Neil A. Hanley et al. · 2014 · PLoS ONE
  58. Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in mice
    Su‐Hyung Lee, Junwon Park, Sang‐Ho Woo, Du‐Min Go, Hyo‐Jung Kwon, Ja‐June Jang, Dae-Yong Kim · 2016 · Oncotarget
  59. Mechanisms of hepatic stellate cell activation as a therapeutic target for the treatment of non-alcoholic steatohepatitis
    Takuma Tsuchida · 2019 · Folia Pharmacologica Japonica
  60. Dissecting the mechanisms of MASLD fibrosis in the era of single-cell and spatial omics
    Fabio Colella, Neil Cowan Henderson, Prakash Ramachandran · 2025 · Journal of Clinical Investigation
  61. Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies
    Guangyan Wang, Xiaoyan Zhang, Chunjiong Wang, Youfei Guan · 2023 · World Journal of Gastroenterology
  62. Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations
    Alexander J. Kovalic, George T. Cholankeril, Sanjaya Kumar Satapathy · 2019 · Translational Gastroenterology and Hepatology
  63. IGF2 mRNA Binding Protein 2 Transgenic Mice Are More Prone to Develop a Ductular Reaction and to Progress Toward Cirrhosis
    Czepukojc, Beate, Abuhaliema, Ali, Barghash, Ahmad, Tierling, Sascha, Naß, Norbert, Simon, Yvette, Körbel, Christina, Cadenas, Cristina, van Hul, Noemi, Sachinidis, Agapios et al. · 2019 · Frontiers in Medicine
  64. Osteopontin in Chronic Inflammatory Diseases: Mechanisms, Biomarker Potential, and Therapeutic Strategies
    Fuyuan Lang, Yuanheng Li, Ruizhe Yao, Meixiu Jiang · 2025 · Biology
  65. Association of Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Stiffness With Bone Mineral Density in American Adults
    Hejun Li, Hengcong Luo, Ying Zhang, Lisi Liu, Rong Lin · 2022 · Frontiers in Endocrinology
  66. Hepatic stellate cell activation by TGFβ induces hedgehog signaling and endoplasmic reticulum stress simultaneously
    Roya Solhi, Abbas Sahebghadam Lotfi, Majid Lotfinia, Zahra Farzaneh, Abbas Piryaei, Mustapha Najimi, Massoud Vosough · 2022 · Toxicology in Vitro
  67. Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication
    Steve S. Choi, Lee C. Claridge, Ravi R. Jhaveri, Marzena Swiderska‐Syn, Paul James Clark, Ayako Suzuki, Thiago Almeida Pereira, Zhiyong Mi, Paul C. Kuo, Cynthia D. Guy et al. · 2014 · Clinical Science
  68. Intrahepatic osteopontin signaling by CREBZF defines a checkpoint for steatosis-to-NASH progression
    Fengguang Ma, Yuxiao Liu, Zhimin Hu, Yaqian Xue, Zhengshuai Liu, Genxiang Cai, Weitong Su, Zengpeng Zheng, Fang Xia, Xi Yan et al. · 2023 · Hepatology
  69. Ethanol Administration Impairs Pancreatic Repair After Injury
    Katrina J. Mahan Schneider, Marc Scheer, Mallory J. Suhr Van Haute, Dahn L. Clemens · 2012 · Pancreas
  70. Single-Cell Mapping of Large and Small Arteries During Hypertensive Aging
    Jun Cheng, Hong Wu, Cheng Xie, Yangyan He, Rong Mou, Hongkun Zhang, Yan Yang, Qingbo Xu · 2023 · The Journals of Gerontology Series A
  71. Pathogenesis of Nonalcoholic Fatty Liver Disease
    Mariana Verdelho Machado, Anna Mae Diehl · 2018 · Elsevier eBooks
  72. Pathophysiology of hepatic Na+/H+ exchange (Review)
    Li, Tingting, Tuo, Biguang · 2020 · Experimental and Therapeutic Medicine
  73. Non‐alcoholic steatohepatitis‐associated hepatic fibrosis and hepatocellular carcinoma in a combined mouse model of genetic modification and dietary challenge
    Yuichiro Amano, Fumi Shimizu, Hironobu Yasuno, Ayako Harada, Shuntarou Tsuchiya, Osamu Isono, Hiroshi Nagabukuro, Ryuichi Tozawa · 2016 · Hepatology Research
  74. COVID-19 and fibrosis: Mechanisms, clinical relevance, and future perspectives
    Mohd Aslam Saifi, Sapana Bansod, Chandraiah Godugu · 2022 · Drug Discovery Today
  75. Elaboration of tubules with active hedgehog drives parenchymal fibrogenesis in gestational alloimmune liver disease
    Akihiro Asai, Samyukta Malladi, Jonathan Misch, Xiaomin Pan, Padmini Malladi, Anna Mae Diehl, Peter F. Whitington · 2014 · Human Pathology
  76. Liver stiffness correlates with serum osteopontin and TAZ expression in human liver cirrhosis
    Zohreh Khajehahmadi, Sina Mohagheghi, Saman Nikeghbalian, Bita Geramizadeh, Iraj Khodadadi, Jamshid Karimi, Heidar Tavilani · 2019 · Annals of the New York Academy of Sciences
  77. Loss of pericyte smoothened activity in mice with genetic deficiency of leptin
    Guanhua Xie, Marzena Swiderska‐Syn, Mark L. Jewell, Mariana Verdelho Machado, Gregory Alexander Michelotti, Richard T. Premont, Anna Mae Diehl · 2017 · BMC Cell Biology
  78. Osteopontin‐driven T‐cell accumulation and function in adipose tissue and liver promoted insulin resistance and MAFLD
    Frédéric Soysouvanh, Déborah Rousseau, Stéphanie Bonnafous, Manon Bourinet, Axelle Strazzulla, Stéphanie Patouraux, Jean Machowiak, Marwin A. Farrugia, Antonio Iannelli, Albert Tran et al. · 2023 · Obesity
  79. Osteopontin upregulation in rotavirus-induced murine biliary atresia requires replicating virus but is not necessary for development of biliary atresia
    Paula Marie Hertel, Sue E. Crawford, Milton J. Finegold, Mary Kolb Estes · 2011 · Virology
  80. PRC1 promotes GLI1-dependent osteopontin expression in association with the Wnt/β-catenin signaling pathway and aggravates liver fibrosis
    Shenzong Rao, Jie Xiang, Jingsong Huang, Shangang Zhang, Min Zhang, Haoran Sun, Jian Li · 2019 · Cell & Bioscience
  81. Second hits exacerbate alcohol-related organ damage: an update
    Natalia A. Osna, Murali Ganesan, Devanshi Seth, Todd A. Wyatt, Srivatsan Kidambi, Kusum K. Kharbanda · 2020 · Alcohol and Alcoholism
  82. LEADS – a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing
    Gowri Manohari Balachander, Inn Chuan Ng, Roopesh R. Pai, Kartik Mitra, Farah Tasnim, Yee Siang Lim, Royston Kwok, Yaqi Song, Lai Ping Yaw, Clarissa Bernice Quah et al. · 2025 · Lab on a Chip
  83. The Neglected Role of Bile Duct Epithelial Cells in NASH
    Massimiliano Cadamuro, Alberto Lasagni, Samantha Sarcognato, Maria Guido, Roberto Fabris, Mario Strazzabosco, Alastair J. Strain, Paolo Simioni, Erica Villa, Luca Fabris · 2021 · Seminars in Liver Disease
  84. Leptin reduces microRNA-122 level in hepatic stellate cells in vitro and in vivo
    Xuguang Zhai, Fangyun Cheng, Ji Li, Xiaofei Zhu, Qing Cao, Yali Zhang, Xin Jia, Qian Zhou, Wei Guan, Yajun Zhou · 2017 · Molecular Immunology
  85. Lipid-injured hepatocytes release sOPN to improve macrophage migration via CD44 engagement and pFak-NFκB signaling
    Xin Jiang, Fan Zhang, Xueying Ji, Fangyuan Dong, Huiyuan Yu, Mengjuan Xue, Yixuan Qiu, Fan Yang, Xiaona Hu, Zhijun Bao · 2021 · Cytokine
  86. Innate-like T lymphocytes in chronic liver disease
    Maria Papanastasatou, Mihalis Verykokakis · 2023 · Frontiers in Immunology
  87. Management and diagnosis of fatty liver disease
    Amanda Schneier, Caitlin Citti, Douglas T. Dieterich · 2015 · Expert Review of Gastroenterology & Hepatology
  88. Is there a role for adaptive immunity in nonalcoholic steatohepatitis?
    S. Sutti, A. Jindal, S. Bruzzì, Irene Locatelli, C. Bozzola, E. Albano · 2015 · World Journal of Hepatology
  89. Pentoxifylline inhibits liver fibrosis via hedgehog signaling pathway
    Hui Li, Juan Hua, Chunxia Guo, Weixian Wang, Baoju Wang, Dongliang Yang, Ping Wei, Yinping Lu · 2016 · Journal of Huazhong University of Science and Technology [Medical Sciences]
  90. Linking fatty liver diseases to hepatocellular carcinoma by hepatic stellate cells
    Liangen Chen, Xiang-Shi Ye, Lixian Yang, Jiang‐Sha Zhao, Jia You, Yuxiong Feng · 2024 · Journal of the National Cancer Center
  91. Matricellular proteins in immunometabolism and tissue homeostasis
    Kyoungjun Eun, Ah Young Kim, Seungjin Ryu · 2024 · BMB Reports
  92. Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis
    Ying‐Ying Yang, Yi‐Tsau Huang, Tung‐Hu Tsai, Ming‐Chih Hou, Fa‐Yauh Lee, Shou‐Dong Lee, Han‐Chieh Lin · 2012 · Clinical Science
  93. Triptolide increases resistance to bile duct ligation-induced liver injury and fibrosis in mice by inhibiting RELB
    Zihang Yuan, Jie Wang, Haoran Zhang, Yingying Miao, Qianhui Tang, Ziqiao Yuan, Cheng Nong, Zhicheng Duan, Luyong Zhang, Zhenzhou Jiang et al. · 2022 · Frontiers in Nutrition
  94. Ductular reaction in non-alcoholic fatty liver disease: When Macbeth is perverted
    Yang-Huan He, Jiaxing Pan, Leiming Xu, Ting Gu, Yuanwen Chen · 2023 · World Journal of Hepatology
  95. Osteokines in Nonalcoholic Fatty Liver Disease
    Ilias D. Vachliotis, Athanasios D. Anastasilakis, Vasileios D. Rafailidis, Stergios A. Pοlyzos · 2024 · Current Obesity Reports
  96. Obeticholic acid aggravates liver injury by up-regulating the liver expression of osteopontin in obstructive cholestasis
    Jie Wang, Zihang Yuan, Haoran Zhang, Qipeng Wu, Yingying Miao, Yunxia Xu, Qinwei Yu, Xiaofei Huang, Ziling Zhang, Xinliang Huang et al. · 2022 · Life Sciences
  97. Alteration in immune function in patients with fatty liver disease
    Stephanie N. Gregory, Shruthi Reddy Perati, Zachary J. Brown · 2022 · Hepatoma Research
  98. Cytokine Production and Signaling in Stellate Cells
    Fabio Marra, Alessandra Caligiuri · 2015 · Elsevier eBooks
  99. Serum osteopontin is a biomarker of severe fibrosis and portal hypertension in human and murine schistosomiasis mansoni
    Thiago Almeida Pereira, Wing‐Kin Syn, Fausto Edmundo Lima Pereira, José Roberto Lambertucci, William Evan Secor, Anna Mae Diehl · 2016 · International Journal for Parasitology
  100. Adult Hepatocytes Are Hedgehog-Responsive Cells in the Setting of Liver Injury
    Ying Wang, Weina Chen, Chang Han, Jinqiang Zhang, Kyoungsub Song, Hyunjoo Kwon, Srikanta Dash, Yao Wei W Lu, Tong Wu · 2018 · American Journal Of Pathology